A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients
Biyun Wang, Yannan Zhao, Yi Li, Yingying Xu, Yun Chen, Qiuyu Jiang, Dingjin Yao, Li Zhang, Xichun Hu, Chaowei Fu, Si Zhang, She Chen
Topics & Concepts
Triple-negative breast cancerBiologyBreast cancerCancerOncologyInternal medicineCancer researchMetastatic breast cancerMedicineGeneticsThyroid Cancer Diagnosis and TreatmentBiomarkers in Disease MechanismsFerroptosis and cancer prognosis